Private placement in Cytovation ASA (NO) — NOK 180 million

Carnegie acted as joint bookrunner in the private placement of NOK 180 million in new equity. Cytovation is a Norwegian clinical-stage biotech spin-off from University of Bergen with over 15 years of cutting-edge research within immunotherapy.
January 2022.